indomethacin has been researched along with Ovarian Diseases in 4 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Ovarian Diseases: Pathological processes of the OVARY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of pharmacologic doses of gonadotropin-releasing hormone, danazol, and indomethacin on the clinical and endocrinologic features of the ovarian hyperstimulation syndrome were studied in the rabbit." | 7.67 | Relationship of gonadotropin-releasing hormone, danazol, and prostaglandin blockade to ovarian enlargement and ascites formation of the ovarian hyperstimulation syndrome in the rabbit. ( Leung, PC; Moon, YS; Pride, SM; Yuen, BH, 1986) |
| " Groups A and B1 received intravascular volume expander, electrolytes replacement, and indomethacin up to 300 mg/day." | 3.67 | Severe ovarian hyperstimulation syndrome: a reevaluated therapeutic approach. ( Borenstein, R; Elhalah, U; Lunenfeld, B; Schwartz, ZS, 1989) |
| "The effects of pharmacologic doses of gonadotropin-releasing hormone, danazol, and indomethacin on the clinical and endocrinologic features of the ovarian hyperstimulation syndrome were studied in the rabbit." | 3.67 | Relationship of gonadotropin-releasing hormone, danazol, and prostaglandin blockade to ovarian enlargement and ascites formation of the ovarian hyperstimulation syndrome in the rabbit. ( Leung, PC; Moon, YS; Pride, SM; Yuen, BH, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaytán, F | 1 |
| Gaytán, M | 1 |
| Castellano, JM | 1 |
| Romero, M | 1 |
| Roa, J | 1 |
| Aparicio, B | 1 |
| Garrido, N | 1 |
| Sánchez-Criado, JE | 1 |
| Millar, RP | 1 |
| Pellicer, A | 1 |
| Fraser, HM | 1 |
| Tena-Sempere, M | 1 |
| Katz, Z | 1 |
| Lancet, M | 1 |
| Borenstein, R | 2 |
| Chemke, J | 1 |
| Elhalah, U | 1 |
| Lunenfeld, B | 1 |
| Schwartz, ZS | 1 |
| Pride, SM | 1 |
| Yuen, BH | 1 |
| Moon, YS | 1 |
| Leung, PC | 1 |
4 other studies available for indomethacin and Ovarian Diseases
| Article | Year |
|---|---|
KiSS-1 in the mammalian ovary: distribution of kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction.
Topics: Animals; Callithrix; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Female; Gene E | 2009 |
Absence of teratogenicity of indomethacin in ovarian hyperstimulation syndrome.
Topics: Adult; Chorionic Gonadotropin; Female; Fertilization; Humans; Indomethacin; Infant, Newborn; Menotro | 1984 |
Severe ovarian hyperstimulation syndrome: a reevaluated therapeutic approach.
Topics: Abortion, Missed; Adult; Ascites; Drainage; Electrolytes; Female; Humans; Indomethacin; Ovarian Dise | 1989 |
Relationship of gonadotropin-releasing hormone, danazol, and prostaglandin blockade to ovarian enlargement and ascites formation of the ovarian hyperstimulation syndrome in the rabbit.
Topics: Animals; Ascites; Danazol; Female; Follicle Stimulating Hormone; Indomethacin; Luteinizing Hormone; | 1986 |